Investing Profile

Frank Kalkbrenner

InvestorVC
Director, Investment Manager at Boehringer Ingelheim Venture Fund
Photo of Frank Kalkbrenner, Investor at Boehringer Ingelheim Venture Fund
cb
$3.3M - $17.0M
$8.5M
9
CompanyStageDateRound SizeTotal Raised
Rinri Therapeutics
Series UnknownApr 2021$12M
$14M
Co-investors: Claire Brown (Oxford Science Enterprises)
T3 Pharmaceuticals
Series CJul 2020$27M
Series BSep 2019$12M
$39M
Amal Therapeutics
Series BNov 2018$33M
Series BSep 2017$10M
Series AMar 2016$3M
$46M
Co-investors: Frank Hensel (High-Tech Gründerfonds)
Hookipa Pharma
Series CDec 2017$60M
Series BDec 2016$11M
Series BNov 2013$27M
$110M
Co-investors: Graziano Seghezzi (Soffinova Partners)